Pfizer’s Abrysvo is designed to prevent RSV-associated disease in infants
Category: News
The update is aimed at strengthening local and national surveillance
The company is preparing to submit the results to the FDA this year
The agency has launched a whole genome sequencing service to monitor the virus
VIDAR-1 trial marks company’s clinical-stage debut
Collaboration brings remote care to cancer patients
EC extends brexpiprazole indication to include adolescents
Immunoglobulin therapy improves mobility in phase 2/3 study
Phase 2a TREE study assesses safety and efficacy of leriglitazone
Company seeks new direction after negative CHMP opinion on KIZFIZO